Peptide Encyclopedia / Lipo-B
EncyclopediaLipo-B is a compounded lipotropic injection of methionine, inositol, and choline with vitamin B12, marketed to aid fat metabolism and energy. Rigorous evidence for weight loss is minimal, and the blend holds no FDA approval, reaching users through compounding pharmacies. Below you'll find reported dosing, reconstitution, safety, and legal status. Educational only, not medical advice.
| Category | GLP-1 / Metabolic |
| Regulatory status | Not FDA-approved as a weight-loss product; provided through compounding pharmacies. |
A compounded 'lipotropic' injection, commonly methionine, inositol, and choline with vitamin B12 (formulations vary; 'B' often denotes the B12 emphasis), marketed to aid fat metabolism and energy. Efficacy of the blend for weight loss is not established.
Not applicable/uncertain; a multi-component blend without a single defined half-life. Commonly reported use/dosing: Marketed as periodic intramuscular/subcutaneous injections in wellness/weight-loss clinics. No FDA-approved protocol; reported dosing is clinic-specific.
Not FDA-approved as a weight-loss product; provided through compounding pharmacies. The lipotropic combination lacks FDA approval for fat loss.
Typically injection-site reactions, transient GI symptoms, or flushing; compounded product sterility/quality concerns. Weight-loss efficacy unproven.
Minimal rigorous clinical evidence; largely compounding-pharmacy/marketing practice rather than validated therapy.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. Lipo-B may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.
